Multiple Assemblies exist for SMTL entry 5sfy
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH n2c(c1nc(nn1c(c2)C)\\C=C\\c3nc(nn3C)c4c[nH]nc4)C, micromolar IC50=0.22176; X-RAY DIFFRACTION 2.08 Å

SMTL ID
5sfy.1
Ligands
ZINC ION; MAGNESIUM ION; (4S)-5,8-dimethyl-2-{(E)-2-[1-methyl-3-(1H-pyrazol-4-yl)-1H-1,2,4-triazol-5-yl]ethenyl}[1,2,4]triazolo[1,5-a]pyrazine
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5sfy.2
Ligands
ZINC ION; MAGNESIUM ION; (4S)-5,8-dimethyl-2-{(E)-2-[1-methyl-3-(1H-pyrazol-4-yl)-1H-1,2,4-triazol-5-yl]ethenyl}[1,2,4]triazolo[1,5-a]pyrazine
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5sfy.3
Ligands
ZINC ION; MAGNESIUM ION; (4S)-5,8-dimethyl-2-{(E)-2-[1-methyl-3-(1H-pyrazol-4-yl)-1H-1,2,4-triazol-5-yl]ethenyl}[1,2,4]triazolo[1,5-a]pyrazine
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5sfy.4
Ligands
ZINC ION; MAGNESIUM ION; (4S)-5,8-dimethyl-2-{(E)-2-[1-methyl-3-(1H-pyrazol-4-yl)-1H-1,2,4-triazol-5-yl]ethenyl}[1,2,4]triazolo[1,5-a]pyrazine
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer